Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer

NCT01986569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: [18F]fluoroestradiol (FES)

Sponsor

Asan Medical Center